Genome & Company Market Cap

Genome & Company has a market cap or net worth of 230.99 billion as of April 10, 2026. Its market cap has increased by 207.06% in one year.

Market Cap

230.99B

Enterprise Value

226.62B

Revenue

24.59B

Ranking

n/a

PE Ratio

n/a

Stock Price

6,660.00

Market Cap Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 230.99B, an increase of 221.36%. That is a compound annual growth rate of 17.37%.

Market Cap History

Date	Market Cap	% Change
Apr 9, 2026	232.39B	-2.52%
Dec 30, 2025	238.38B	179.77%
Dec 30, 2024	85.21B	-51.64%
Dec 28, 2023	176.21B	-28.34%
Dec 29, 2022	245.90B	-47.55%
Dec 30, 2021	468.83B	-55.28%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 26, 2018	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
S.Biomedics	342.45B
Kangstem Biotech	300.97B
TiumBio	299.51B
curacle co.,ltd.	293.36B
NIBEC	290.97B
Bio Solution	268.31B
ABION	199.57B
ISU Abxis	181.83B

Market Cap Rankings